株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

麻酔・呼吸・睡眠管理装置の米国市場 (2019-2025年):11レポートセット

Anesthesia, Respiratory and Sleep Management Device Market Report Suite | United States | 2019-2025 | MedSuite (Includes 11 Reports)

発行 iData Research Inc. 商品コード 795305
出版日 ページ情報 英文 583 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
麻酔・呼吸・睡眠管理装置の米国市場 (2019-2025年):11レポートセット Anesthesia, Respiratory and Sleep Management Device Market Report Suite | United States | 2019-2025 | MedSuite (Includes 11 Reports)
出版日: 2019年01月02日 ページ情報: 英文 583 Pages
概要

当レポートセットでは、米国における麻酔・呼吸・睡眠管理装置の市場を調査し、対象疾患の概要、患者人口統計、製品ポートフォリオ、臨床試験およびリコール対象製品、製品区分別の主要動向、市場成長への各種影響因子の分析、市場規模の推移と予測、競合環境と市場シェアなどをまとめています。

エグゼクティブサマリー

第1章 米国における麻酔・呼吸・睡眠管理装置市場の概要

  • 競合分析
  • 市場動向
  • 市場発展
  • 対象市場
  • 主要レポートのアップデート
  • バージョン履歴
  • 調査手法

第2章 疾病の概要

  • 基本構造
  • 疾病の治療・診断
  • 患者統計

第3章 製品評価

  • イントロダクション
  • 製品ポートフォリオ
  • 法規制上の課題・リコール
  • 臨床試験

第4章 米国における麻酔・呼吸・睡眠管理装置市場の概要

  • イントロダクション
  • 市場概要
  • 動向分析:区分別
  • 成長推進因子・抑制因子
  • 競合市場シェア分析
  • M&A
  • 企業プロファイル
  • SWOT分析

第5章 麻酔デリバリーユニット市場

  • イントロダクション
  • 市場概要
  • 動向分析・予測
  • 設置基盤の分析
  • 成長推進因子・抑制因子
  • 競合市場シェア分析

第6章 麻酔モニター市場

  • イントロダクション
  • 市場概要
  • 動向分析・予測
  • 成長推進因子・抑制因子
  • 競合市場シェア分析

第7章 麻酔情報管理システム市場

第8章 麻酔用使い捨て用品市場

第9章 人工呼吸器市場

第10章 ネブライザー市場

第11章 呼吸用使い捨て用品市場

第12章 酸素療法市場

第13章 閉塞型睡眠時無呼吸症候 (OSA) 治療装置市場

第14章 睡眠診断装置市場

略語

付録:企業のプレスリリース

図表

LIST OF CHARTS

  • Chart 1-1: Dental Implant and Final Abutment Market by Segment, U.S., 2015 - 2025
  • Chart 1-2: Dental Implant and Final Abutment Market Overview, U.S., 2018 & 2025
  • Chart 4-1: Dental Implant and Final Abutment Market by Segment, U.S., 2015 - 2025
  • Chart 4-2: Dental Implant and Final Abutment Market Breakdown, U.S., 2018
  • Chart 4-3: Dental Implant and Final Abutment Market Breakdown, U.S., 2025
  • Chart 4-4: Growth Rates by Segment, Dental Implant and Final Abutment Market, U.S., 2015 - 2025
  • Chart 4-5: Leading Competitors, Dental Implant and Final Abutment Market, U.S., 2018
  • Chart 5-1: Dental Implant Market by Segment, U.S., 2015 - 2025
  • Chart 5-2: Dental Implant Market Breakdown, U.S., 2018
  • Chart 5-3: Dental Implant Market Breakdown, U.S., 2025
  • Chart 5-4: Total Dental Implant Market, U.S., 2015 - 2025
  • Chart 5-5: Premium Dental Implant Market, U.S., 2015 - 2025
  • Chart 5-6: Value Dental Implant Market, U.S., 2015 - 2025
  • Chart 5-7: Discount Dental Implant Market, U.S., 2015 - 2025
  • Chart 5-8: Mini Dental Implant Market, U.S., 2015 - 2025
  • Chart 5-9: Dental Implant Units Sold by Procedure Type, U.S., 2015 - 2025
  • Chart 5-10: Dental Implant Units Sold by Shape, U.S., 2015 - 2025
  • Chart 5-11: Dental Implant Units Sold by Connection Type, U.S., 2015 - 2025
  • Chart 5-12: Dental Implant Units Sold by Application, U.S., 2015 - 2025
  • Chart 5-13: Denture Securement Implant Units Sold by Denture Type, U.S., 2015 - 2025
  • Chart 5-14: Dental Implant Units Sold by Material, U.S., 2015 - 2025
  • Chart 5-15: Leading Competitors, Dental Implant Market, U.S., 2018
  • Chart 6-1: Final Abutment Market by Segment, U.S., 2015 - 2025
  • Chart 6-2: Final Abutment Market Breakdown, U.S., 2018
  • Chart 6-3: Final Abutment Market Breakdown, U.S., 2025
  • Chart 6-4: Total Final Abutment Market, U.S., 2015 - 2025
  • Chart 6-5: Stock Abutment Market, U.S., 2015 - 2025
  • Chart 6-6: Custom Cast Abutment Market, U.S., 2015 - 2025
  • Chart 6-7: CAD/CAM Abutment Market, U.S., 2015 - 2025
  • Chart 6-8: Final Abutment Units Sold by Type, U.S., 2015 - 2025
  • Chart 6-9: Final Abutment Units Sold by Material, U.S., 2015 - 2025
  • Chart 6-10: CAD/CAM Units Sold by Milling Process, U.S., 2015 - 2025
  • Chart 6-11: Leading Competitors, Final Abutment Market, U.S., 2018
  • Chart 7-1: Dental Implant Instrument Kit Market by Segment, U.S., 2015 - 2025
  • Chart 7-2: Dental Implant Instrument Kit Market Breakdown, U.S., 2018
  • Chart 7-3: Dental Implant Instrument Kit Market Breakdown, U.S., 2025
  • Chart 7-4: Dental Implant Instrument Kit Market, U.S., 2015 - 2025
  • Chart 7-5: Leading Competitors, Dental Implant Instrument Kit Market, U.S., 2018
  • Chart 8-1: Treatment Planning Software Market by Segment, U.S., 2015 - 2025
  • Chart 8-2: Treatment Planning Software Market Breakdown, U.S., 2018
  • Chart 8-3: Treatment Planning Software Market Breakdown, U.S., 2025
  • Chart 8-4: Treatment Planning Software Market, U.S., 2015 - 2025
  • Chart 8-5: Treatment Planning Software Maintenance Fees, U.S., 2015 - 2025
  • Chart 8-6: Leading Competitors, Treatment Planning Software Market, U.S., 2018
  • Chart 9-1: Surgical Guide Market by Segment, U.S., 2015 - 2025
  • Chart 9-2: Surgical Guide Market Breakdown, U.S., 2018
  • Chart 9-3: Surgical Guide Market Breakdown, U.S., 2025
  • Chart 9-4: Traditional Surgical Guide Market, U.S., 2015 - 2025
  • Chart 9-5: Third-Party Surgical Guide Market, U.S., 2015 - 2025
  • Chart 9-6: In-House Printed Surgical Guide Market, U.S., 2015 - 2025
  • Chart 9-7: Leading Competitors, Surgical Guide Market, U.S., 2018

LIST OF FIGURES

  • Figure 1-1: Dental Implant and Final Abutment Market Share Ranking by Segment, U.S., 2018
  • Figure 1-2: Companies Researched in this Report, U.S., 2018
  • Figure 1-3: Factors Impacting the Dental Implant and Final Abutment Market by Segment, U.S.
  • Figure 1-4: Recent Events in the Dental Implant and Final Abutment Market, U.S., 2015 - 2018 (1 of 2)
  • Figure 1-5: Recent Events in the Dental Implant and Final Abutment Market, U.S., 2015 - 2018 (2 of 2)
  • Figure 1-6: Dental Implant and Final Abutment Markets Covered, U.S., 2018 (1 of 2)
  • Figure 1-7: Key Report Updates
  • Figure 1-8: Version History
  • Figure 3-1: Dental Implant Products by Company (1 of 4)
  • Figure 3-2: Dental Implant Products by Company (2 of 4)
  • Figure 3-3: Dental Implant Products by Company (3 of 4)
  • Figure 3-4: Dental Implant Products by Company (4 of 4)
  • Figure 3-5: Dental Abutment Products by Company (1 of 3)
  • Figure 3-6: Dental Abutment Products by Company (2 of 3)
  • Figure 3-7: Dental Abutment Products by Company (3 of 3)
  • Figure 3-8: Treatment Planning Software Products by Company (1 of 2)
  • Figure 3-9: Surgical Guide Products by Company
  • Figure 3-10: Dental Instrument Kit Products by Company
  • Figure 3-11: Class 2 Device Recall Prima Plus, Keystone Dental Inc.
  • Figure 3-12: Class 2 Device Recall ImplantDirect simply InterActive Implant, Part 655010U
  • Figure 3-13: Class 2 Device Recall SwishTapered Implant
  • Figure 3-14: Class 2 Device Recall MTX Dental Implant
  • Figure 3-15: Class 2 Device Recall MTX Dental Implant
  • Figure 3-16: Class 3 Device Recall Stage1 Dental Implant
  • Figure 3-17: Class 2 Device Recall Legacy(TM) 3 Implant
  • Figure 3-18: Class 2 Device Recall Max Implant System
  • Figure 3-19: Class 2 Device Recall BIOMET 3i LTX DENTAL IMPLANTS
  • Figure 3-20: Class 2 Device Recall Legacy 4 Implant
  • Figure 3-21: Class 2 Device Recall 3I OSSEOTITE® CERTAIN® DENTAL IMPLANTS, Biomet 3i
  • Figure 3-22: Class 2 Device Recall Keystone Dental Prima Connex Straight Implant TC
  • Figure 3-23: Class 2 Device Recall CERTAIN® brand by Biomet 3i, LLC (1-1)
  • Figure 3-24: Class 2 Device Recall CERTAIN® brand by Biomet 3i, LLC (1-2)
  • Figure 3-25: Class 2 Device Recall Locator® brand by Biomet 3i, LLC
  • Figure 3-26: Class 2 Device Recall Straumann Bone Level Implant
  • Figure 3-27: Class 2 Device Recall Axiom 2.8, Anthogyr
  • Figure 3-28: Class 2 Device Recall GoDirect, Implant Direct Sybron Manufacturing, LLC
  • Figure 3-29: Class 2 Device Recall Trabecular Metal Zimmer Dental implant
  • Figure 3-30: Class 2 Device Recall RBT, Internal Implant, LaserLok, 5.0 x 15mm, 5.7 Platform, BioHorizons Implant Systems Inc
  • Figure 3-31: Class 2 Device Recall External Implant RBT, D3 Threadform 4.0 X 10.5mm, REF 40105D3, BioHorizons Implant Systems Inc
  • Figure 3-32: Class 2 Device Recall Osseotite Dental Implants, Biomet 3i
  • Figure 3-33: Class 2 Device Recall REPLANT 5.0mmD ABUTMENT, Part number 60505260
  • Figure 3-34: Class 2 Device Recall RESTORE, STAGE1, RENOVA PRIMASOLO AND PRIMACONNEX DENTAL IMPLANTS
  • Figure 3-35: Class 2 Device Recall PrimaConnex Implant System
  • Figure 3-36: Class 2 Device Recall INFINITY Internal Hex Healing Abutment
  • Figure 3-37: Class 2 Device Recall Conical® Abutment Dental Implants by Biomet 3i, LLC
  • Figure 3-38: Class 2 Device Recall OIL® brand by Biomet 3i, LLC
  • Figure 3-39: Class 2 Device Recall Other Dental Implants, Abutments and Components by Biomet 3i, LLC (1-1)
  • Figure 3-40: Class 2 Device Recall Other Dental Implants, Abutments and Components by Biomet 3i, LLC (1-2)
  • Figure 3-41: Class 2 Device Recall UCLA Abutment Hexed Castable Cylinder 3.4mm
  • Figure 3-42: Class 2 Device Recall Abutment Retrieval Instrument
  • Figure 3-43: Class 2 Device Recall BellaTek Zirconia Dental Abutment, Biomet 3i, LLC
  • Figure 3-44: Class 2 Device Recall XGuide Surgical Navigation System
  • Figure 3-45: Class 2 Device Recall Genesis Surgical Cassette Tapered
  • Figure 3-46: Class 2 Device Recall Zimmer Dental Tapered SwissPlus & SwissPlus Implant Systems surgical kit
  • Figure 3-47: Class 2 Device Recall Dental Instruments, Biomet 3i
  • Figure 3-48: Class 2 Device Recall Tapered HD Upgrade Set, REF TSKHDUS
  • Figure 3-49: Class 2 Device Device Recall Replace Select Tapered TiU NP, Nobel Biocare
  • Figure 3-50: Survival Rate of Dental Implants (OsseoSpeed™)
  • Figure 3-51: Monolithic Zirconia Crowns for Single Implants in the Molar Region: a Multicenter Clinical Trial (MonoZrO2crown)
  • Figure 3-52: CF41102 5-year Clinical Evaluation of Conelog® Implant With 7 mm Length (UKAConelog)
  • Figure 3-53: Short vs Long Dental Implants for the Fixed Rehabilitation of the Fully Edentulous Mandible
  • Figure 3-54: Zolidd One ExHex Dental Implant Compared to Uncoated One ExHex Dental Implant in Subjects With Partial Edentulism
  • Figure 3-55: Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration
  • Figure 3-56: Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants
  • Figure 3-57: Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System (OAK)
  • Figure 3-58: A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant (ICE)
  • Figure 3-59: Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants
  • Figure 3-60: Maxillary 3-implant Removable Prostheses Without Palatal Coverage on Locator Abutments
  • Figure 3-61: Early Loading of Dental Implants; A Prospective Study in the Mandibular First Molar Area
  • Figure 3-62: Controlled Pilot Study to Assess Soft Tissue Reaction at the Crestal Part of a Dental Implant With ESTA Surface
  • Figure 3-63: Survival and Success of MIS C1 Implants
  • Figure 3-64: Clinical Assessment of Dental Implant (H2015-1)
  • Figure 3-65: A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant (SPI)
  • Figure 3-66: Comparing Conventional Dental Implants and Trabecular Metal™ Dental Implants After Sinus Floor Elevation
  • Figure 3-67: Performance of MicroTextured Dental Implants
  • Figure 3-68: Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept
  • Figure 3-69: Multicenter Study Comparing OsseoSpeed TX With OsseoSpeed EV
  • Figure 3-70: Zirconia Based Fixed Dental Prostheses
  • Figure 3-71: Abutment Macro Design and Peri-implant Tissues
  • Figure 3-72: Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants
  • Figure 3-73: Laser-Lok Pilot Study
  • Figure 3-74: Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants
  • Figure 3-75: Computer Guided Versus Free Hand Immediate Implant Placement
  • Figure 3-76: Accuracy in Computer Guided Versus Free Hand Immediate Implantation (RCT)
  • Figure 3-77: Assessment of the Accuracy of Surgical Guide Designed From Dental Model Optical Scan Versus Impression Inversion With Markers Techniques in Computer Guided Implantology. Randomized Clinical Trial.
  • Figure 3-78: Accuracy of Guided Implant Placement Using Double Versus Triple Scan Protocol in Completely Edentulous Patients
  • Figure 3-79: The Effect of Printing Layer Thickness on the Accuracy of Computer Aided Surgical Guides
  • Figure 3-80: MGUIDE MORE Dental Implant Planning System- Clinical Accuracy Study
  • Figure 3-81: MGUIDE MORE Dental Implant Planning System- Clinical Accuracy Study
  • Figure 3-82: Dental Implants Placed by Using a Drill Guide Versus Non-guided Placement. Follow-up Study
  • Figure 4-1: General Practitioner Implant Placement and Restoration Penetration, U.S., 2015 - 2025
  • Figure 4-2: Dental Implants Placed by End User Specialization, U.S., 2015 - 2025
  • Figure 4-3: Dental Implant and Final Abutment Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 4-4: Dental Implant and Final Abutment Market Growth by Segment, U.S., 2015 - 2025
  • Figure 4-5: Drivers and Limiters, Dental Implant and Final Abutment Market, U.S., 2018
  • Figure 4-6: Leading Competitors, Dental Implant and Final Abutment Market, U.S., 2018
  • Figure 4-7: SWOT Analysis, Adin, 2018
  • Figure 4-8: SWOT Analysis, Anatomage, 2018
  • Figure 4-9: SWOT Analysis, BioHorizons, 2018
  • Figure 4-10: SWOT Analysis, CAMLOG, 2018
  • Figure 4-11: SWOT Analysis, Dentsply Sirona, 2018
  • Figure 4-12: SWOT Analysis, DIO Implant, 2018
  • Figure 4-13: SWOT Analysis, Implant Direct, 2018
  • Figure 4-14: SWOT Analysis, Kyocera, 2018
  • Figure 4-15: SWOT Analysis, Neobiotech, 2018
  • Figure 4-16: SWOT Analysis, Nobel Biocare, 2018
  • Figure 4-17: SWOT Analysis, Osstem Implant, 2018
  • Figure 4-18: SWOT Analysis, Southern Implants, 2018
  • Figure 4-19: SWOT Analysis, Straumann, 2018
  • Figure 4-20: SWOT Analysis, Sweden & Martina, 2018
  • Figure 4-21: SWOT Analysis, Zimmer Biomet, 2018
  • Figure 5-1: Dental Implant Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 5-2: Total Dental Implant Market, U.S., 2015 - 2025
  • Figure 5-3: Premium Dental Implant Market, U.S., 2015 - 2025
  • Figure 5-4: Value Dental Implant Market, U.S., 2015 - 2025
  • Figure 5-5: Discount Dental Implant Market, U.S., 2015 - 2025
  • Figure 5-6: Mini Dental Implant Market, U.S., 2015 - 2025
  • Figure 5-7: Dental Implant Units Sold by Procedure Type, U.S., 2015 - 2025
  • Figure 5-8: Dental Implant Units Sold by Shape, U.S., 2015 - 2025
  • Figure 5-9: Dental Implant Units Sold by Connection Type, U.S., 2015 - 2025
  • Figure 5-10: Dental Implant Units Sold by Application, U.S., 2015 - 2025
  • Figure 5-11: Denture Securement Implant Units Sold by Denture Type, U.S., 2015 - 2025
  • Figure 5-12: Dental Implant Units Sold by Material, U.S., 2015 - 2025
  • Figure 5-13: Drivers and Limiters, Dental Implant Market, U.S., 2018
  • Figure 5-14: Leading Competitors, Dental Implant Market, U.S., 2018
  • Figure 6-1: Final Abutment Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 6-2: Total Final Abutment Market, U.S., 2015 - 2025
  • Figure 6-3: Stock Abutment Market, U.S., 2015 - 2025
  • Figure 6-4: Custom Cast Abutment Market, U.S., 2015 - 2025
  • Figure 6-5: CAD/CAM Abutment Market, U.S., 2015 - 2025
  • Figure 6-6: Final Abutment Units Sold by Type, U.S., 2015 - 2025
  • Figure 6-7: Final Abutment Units Sold by Material, U.S., 2015 - 2025
  • Figure 6-8: CAD/CAM Units Sold by Milling Process, U.S., 2015 - 2025
  • Figure 6-9: Drivers and Limiters, Final Abutment Market, U.S., 2018
  • Figure 6-10: Leading Competitors, Final Abutment Market, U.S., 2018
  • Figure 7-1: Dental Implant Instrument Kit Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 7-2: Dental Implant Instrument Kit Market, U.S., 2015 - 2025
  • Figure 7-3: Drivers and Limiters, Dental Implant Instrument Kit Market, U.S., 2018
  • Figure 7-4: Leading Competitors, Dental Implant Instrument Kit Market, U.S., 2018
  • Figure 8-1: Treatment Planning Software Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 8-2: Treatment Planning Software Market, U.S., 2015 - 2025
  • Figure 8-3: Treatment Planning Software Maintenance Fees, U.S., 2015 - 2025
  • Figure 8-4: Drivers and Limiters, Treatment Planning Software Market, U.S., 2018
  • Figure 8-5: Leading Competitors, Treatment Planning Software Market, U.S., 2018
  • Figure 9-1: Surgical Guide Market by Segment, U.S., 2015 - 2025 (US$M)
  • Figure 9-2: Traditional Surgical Guide Market, U.S., 2015 - 2025
  • Figure 9-3: Third-Party Surgical Guide Market, U.S., 2015 - 2025
  • Figure 9-4: In-House Printed Surgical Guide Market, U.S., 2015 - 2025
  • Figure 9-5: Drivers and Limiters, Surgical Guide Market, U.S., 2018
  • Figure 9-6: Leading Competitors, Surgical Guide Market, U.S., 2018
  • Figure 11-1: Press Release Summary
目次
Product Code: iDATA_USARS19_MS

This anesthesia, respiratory and sleep apnea market includes analysis for anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.

The markets for anesthesia disposables, delivery units and monitors, along with the nebulizer and ventilator markets, are set to demonstrate lower levels of growth than other sectors. These markets are saturated with capital equipment and disposables and are growing only marginally alongside the growth in procedures and innovating new features. On the other hand, the markets for therapeutic sleep management devices and oxygen therapy devices are set to grow over the forecast period. In addition to technological innovation, these markets are set to improve as a result of increasing diagnoses through rising patient awareness.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. ANESTHESIA, RESPIRATORY AND SLEEP MANAGEMENT DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Respiratory System
  • 2.2. DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1. Chronic Obstructive Pulmonary Disease
    • 2.2.2. Sleep Apnea
      • 2.2.2.1. OSA
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. COPD Incidence
    • 2.3.2. OSA Incidence

PRODUCT ASSESSMENT

  • 3.1. INTRODUCTION
  • 3.2. PRODUCT PORTFOLIOS
    • 3.2.1. Anesthesia Delivery Unit
    • 3.2.2. Anesthesia Monitor
    • 3.2.3. Anesthesia Disposables
      • 3.2.3.1. Anesthesia Circuits
      • 3.2.3.2. Anesthesia Masks
      • 3.2.3.3. Endotracheal Tubes
      • 3.2.3.4. Laryngeal Masks
    • 3.2.4. Ventilators
      • 3.2.4.1. Acute care Ventilators
      • 3.2.4.2. Sub-Acute Ventilators
      • 3.2.4.3. Home Care Ventilators
      • 3.2.4.4. Neonatal Ventilators
      • 3.2.4.5. Non-Invasive Ventilators
    • 3.2.5. Nebulizers
    • 3.2.6. Respiratory Disposables
      • 3.2.6.1. Oxygen Cannula
      • 3.2.6.2. Oxygen Masks
      • 3.2.6.3. Tracheostomy Tubes
      • 3.2.6.4. Resuscitators
    • 3.2.7. Oxygen Therapy
      • 3.2.7.1. Compressed Gas Cylinders
      • 3.2.7.2. Oxygen Concentrators
      • 3.2.7.3. Transfilling Devices
      • 3.2.7.4. Regulators
      • 3.2.7.5. Conservers
      • 3.2.7.6. Liquid Oxygen
    • 3.2.8. Therapeutic Sleep Management
    • 3.2.9. Sleep Diagnostic Devices
      • 3.2.9.1. Type I Sleep Test
      • 3.2.9.2. Type II Sleep Test
      • 3.2.9.3. Type III Sleep Test
      • 3.2.9.4. Type IV Sleep Test
  • 3.3. REGULATORY ISSUES AND RECALLS
    • 3.3.1. Dräger
      • 3.3.1.1. Anesthesia Delivery Unit
      • 3.3.1.2. Anesthesia Information Management System
      • 3.3.1.3. Ventilator
    • 3.3.2. DeVilbiss
      • 3.3.2.1. Therapeutic Obstructive Sleep Apnea
    • 3.3.3. Fisher & Paykel
      • 3.3.3.1. Therapeutic Obstructive Sleep Apnea
    • 3.3.4. GE Healthcare
      • 3.3.4.1. Anesthesia Delivery Unit
      • 3.3.4.2. Anesthesia Monitor
    • 3.3.5. Invacare
      • 3.3.5.1. Oxygen Therapy
    • 3.3.6. Medtronic
      • 3.3.6.1. Respiratory Disposables
    • 3.3.7. Philips
      • 3.3.7.1. Anesthesia Monitor
      • 3.3.7.2. Anesthesia Information Management System
      • 3.3.7.3. Ventilator
      • 3.3.7.4. Nebulizer
    • 3.3.8. ResMed
      • 3.3.8.1. Ventilator
      • 3.3.8.2. Therapeutic Obstructive Sleep Apnea
    • 3.3.9. Teleflex
      • 3.3.9.1. Anesthesia Disposables
      • 3.3.9.2. Respiratory Disposables
    • 3.3.10. Vyaire Medical
      • 3.3.10.1. Anesthesia Disposables
      • 3.3.10.2. Ventilator
  • 3.4. CLINICAL TRIALS
    • 3.4.1. Chart Industries
      • 3.4.1.1. Oxygen Therapy
    • 3.4.2. Dräger
      • 3.4.2.1. Anesthesia Delivery Unit
      • 3.4.2.2. Ventilator
    • 3.4.3. DeVilbiss
      • 3.4.3.1. Nebulizer
      • 3.4.3.2. Therapeutic Obstructive Sleep Apnea
    • 3.4.4. Fisher & Paykel
      • 3.4.4.1. Therapeutic Obstructive Sleep Apnea
    • 3.4.5. GE Healthcare
      • 3.4.5.1. Anesthesia Delivery Unit
      • 3.4.5.2. Anesthesia Monitor
      • 3.4.5.3. Anesthesia Information Management System
    • 3.4.6. Invacare
      • 3.4.6.1. Oxygen Therapy
    • 3.4.7. Medtronic
      • 3.4.7.1. Anesthesia Disposables
    • 3.4.8. Natus
      • 3.4.8.1. Sleep Diagnostic Devices
    • 3.4.9. Philips
      • 3.4.9.1. Anesthesia Monitor
      • 3.4.9.2. Ventilator
      • 3.4.9.3. Nebulizer
      • 3.4.9.4. Oxygen Therapy
      • 3.4.9.5. Therapeutic Obstructive Sleep Apnea
      • 3.4.9.6. Sleep Diagnostic Devices
    • 3.4.10. ResMed
      • 3.4.10.1. Ventilator
      • 3.4.10.2. Therapeutic Obstructive Sleep Apnea
      • 3.4.10.3. Sleep Diagnostic Devices
    • 3.4.11. Teleflex
      • 3.4.11.1. Anesthesia Disposables
      • 3.4.11.2. Respiratory Disposables
    • 3.4.12. Vyaire Medical
      • 3.4.12.1. Ventilator
      • 3.4.12.2. Nebulizer
      • 3.4.12.3. Respiratory Disposables

U.S. ANESTHESIA, RESPIRATORY AND SLEEP MANAGEMENT DEVICE MARKET OVERVIEW

  • 4.1. INTRODUCTION
    • 4.1.1. Related Diseases and Conditions
      • 4.1.1.1. Chronic Obstructive Pulmonary Disease (COPD)
      • 4.1.1.2. Obstructive Sleep Apnea (OSA)
  • 4.2. MARKET OVERVIEW
  • 4.3. TREND ANALYSIS BY SEGMENT
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6. MERGERS AND ACQUISITIONS
  • 4.7. COMPANY PROFILES
    • 4.7.1. Chart Industries
    • 4.7.2. Dräger
    • 4.7.3. DeVilbiss
    • 4.7.4. Fisher & Paykel
    • 4.7.5. GE Healthcare
    • 4.7.6. Invacare
    • 4.7.7. Medtronic
    • 4.7.8. Natus
    • 4.7.9. Omron
    • 4.7.10. Philips
    • 4.7.11. ResMed
    • 4.7.12. Teleflex
    • 4.7.13. Vyaire Medical
  • 4.8. SWOT ANALYSIS
    • 4.8.1. Chart Industries
    • 4.8.2. Dräger
    • 4.8.3. DeVilbiss
    • 4.8.4. Fisher & Paykel
    • 4.8.5. GE Healthcare
    • 4.8.6. Invacare
    • 4.8.7. Medtronic
    • 4.8.8. Natus
    • 4.8.9. Omron
    • 4.8.10. Philips
    • 4.8.11. ResMed
    • 4.8.12. Teleflex
    • 4.8.13. Vyaire Medical

ANESTHESIA DELIVERY UNIT MARKET

  • 5.1. INTRODUCTION
    • 5.1.1. Anesthesia Delivery Unit Classification
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total Anesthesia Delivery Unit Market
    • 5.3.2. Total Hospital OR ADU Market
      • 5.3.2.1. High-Complexity Hospital OR ADU Market
      • 5.3.2.2. Low-Complexity Hospital OR ADU Market
    • 5.3.3. Total Other Hospital Suite ADU Market
      • 5.3.3.1. MRI Suite ADU Market
      • 5.3.3.2. Obstetric Suite ADU Market
      • 5.3.3.3. Other/Alternate Suite ADU Market
    • 5.3.4. Ambulatory Surgery Center ADU Market
      • 5.3.4.1. New and Refurbished ADUs in the ASC
  • 5.4. INSTALLED BASE ANALYSIS
  • 5.5. DRIVERS AND LIMITERS
    • 5.5.1. Market Drivers
    • 5.5.2. Market Limiters
  • 5.6. COMPETITIVE MARKET SHARE ANALYSIS

ANESTHESIA MONITOR MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total Hospital Anesthesia Monitor Market
      • 6.3.1.1. Hospital Preoperative Anesthesia Monitor Market
      • 6.3.1.2. Hospital OR Anesthesia Monitor Market
      • 6.3.1.3. Hospital Post-Anesthesia Care Unit Anesthesia Monitor Market
      • 6.3.1.4. Hospital Obstetric Anesthesia Monitor Market
    • 6.3.2. Total Ambulatory Surgery Center Anesthesia Monitor Market
      • 6.3.2.1. ASC Preoperative Anesthesia Monitor Market
      • 6.3.2.2. ASC OR Anesthesia Monitor Market
      • 6.3.2.3. ASC Post-Anesthesia Care Unit Anesthesia Monitor Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE MARKET SHARE ANALYSIS

ANESTHESIA INFORMATION MANAGEMENT SYSTEM MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Total Anesthesia Information Management System Market
    • 7.3.2. Hospital AIMS Market
    • 7.3.3. Ambulatory Surgery Center AIMS Market
  • 7.4. DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE MARKET SHARE ANALYSIS

ANESTHESIA DISPOSABLES MARKET

  • 8.1. INTRODUCTION
    • 8.1.1. Anesthesia Circuits
    • 8.1.2. Anesthesia Masks
    • 8.1.3. Endotracheal Tubes
    • 8.1.4. Laryngeal Masks
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET ANALYSIS AND FORECAST
    • 8.3.1. Anesthesia Circuit Market
    • 8.3.2. Anesthesia Mask Market
    • 8.3.3. Sample Line Market
    • 8.3.4. Filter/HME Market
    • 8.3.5. Breathing Bag Market
    • 8.3.6. Endotracheal Tube Market
    • 8.3.7. Total Laryngeal Mask Market
      • 8.3.7.1. Disposable Laryngeal Mask Market
      • 8.3.7.2. Reusable Laryngeal Mask Market
  • 8.4. DRIVERS AND LIMITERS
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. COMPETITIVE MARKET SHARE ANALYSIS

VENTILATOR MARKET

  • 9.1. INTRODUCTION
    • 9.1.1. Acute-Care Ventilators
    • 9.1.2. Sub-Acute Ventilators
    • 9.1.3. Home Care Ventilators
    • 9.1.4. Neonatal Ventilators
    • 9.1.5. Non-Invasive Ventilators
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Acute Care Ventilator Market
    • 9.3.2. Sub-Acute Ventilator Market
    • 9.3.3. Home Care Ventilator Market
    • 9.3.4. Total Neonatal Ventilator Market
      • 9.3.4.1. Dedicated Neonatal Ventilator Market
      • 9.3.4.2. High-Frequency Neonatal Ventilator Market
    • 9.3.5. Non-Invasive Ventilator Market
  • 9.4. DRIVERS AND LIMITERS
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. COMPETITIVE MARKET SHARE ANALYSIS

NEBULIZER MARKET

  • 10.1. INTRODUCTION
  • 10.2. MARKET OVERVIEW
  • 10.3. MARKET ANALYSIS AND FORECAST
    • 10.3.1. Total Compressor/Jet Nebulizer Market
      • 10.3.1.1. Stationary Compressor/Jet Nebulizer Market
      • 10.3.1.2. Portable Compressor/Jet Nebulizer Market
    • 10.3.2. Total Vibrating Nebulizer Market
      • 10.3.2.1. Ultrasonic Nebulizer Market
      • 10.3.2.2. Vibrating Mesh Nebulizer Market
  • 10.4. DRIVERS AND LIMITERS
    • 10.4.1. Market Drivers
    • 10.4.2. Market Limiters
  • 10.5. COMPETITIVE MARKET SHARE ANALYSIS

RESPIRATORY DISPOSABLES MARKET

  • 11.1. INTRODUCTION
    • 11.1.1. Oxygen Cannula
    • 11.1.2. Oxygen Masks
    • 11.1.3. Tracheostomy Tubes
    • 11.1.4. Resuscitators
  • 11.2. MARKET OVERVIEW
  • 11.3. MARKET ANALYSIS AND FORECAST
    • 11.3.1. Oxygen Cannula Market
    • 11.3.2. Oxygen Mask Market
    • 11.3.3. Tracheostomy Tube Market
    • 11.3.4. Resuscitator Market
  • 11.4. DRIVERS AND LIMITERS
    • 11.4.1. Market Drivers
    • 11.4.2. Market Limiters
  • 11.5. COMPETITIVE MARKET SHARE ANALYSIS

OXYGEN THERAPY MARKET

  • 12.1. INTRODUCTION
    • 12.1.1. Compressed Gas Cylinders
    • 12.1.2. Oxygen Concentrators
    • 12.1.3. Transfilling Devices
    • 12.1.4. Regulators
    • 12.1.5. Conservers
    • 12.1.6. Liquid Oxygen
  • 12.2. MARKET OVERVIEW
  • 12.3. MARKET ANALYSIS AND FORECAST
    • 12.3.1. Total Oxygen Concentrator Market
      • 12.3.1.1. Stationary Oxygen Concentrator Market
      • 12.3.1.1.1. Standard Stationary Oxygen Concentrator Market
      • 12.3.1.1.2. High-Flow Stationary Oxygen Concentrator Market
      • 12.3.1.2. Ambulatory Oxygen Concentrator Market
      • 12.3.1.2.1. Transportable Oxygen Concentrator Market
      • 12.3.1.2.2. Portable Oxygen Concentrator Market
    • 12.3.2. Transfilling Device Market
    • 12.3.3. Aluminum Medical Oxygen Cylinder Market
      • 12.3.3.1. Ambulatory Aluminum Medical Oxygen Cylinder Market
      • 12.3.3.2. Backup Aluminum Medical Oxygen Cylinder Market
    • 12.3.4. Medical Oxygen Regulator Home Care Market
    • 12.3.5. Oxygen Conserver Market
      • 12.3.5.1. Pneumatic Oxygen Conserver Market
      • 12.3.5.2. Electronic Oxygen Conserver Market
  • 12.4. DRIVERS AND LIMITERS
    • 12.4.1. Market Drivers
    • 12.4.2. Market Limiters
  • 12.5. COMPETITIVE MARKET SHARE ANALYSIS

THERAPEUTIC OBSTRUCTIVE SLEEP APNEA DEVICE MARKET

  • 13.1. INTRODUCTION
  • 13.2. MARKET OVERVIEW
  • 13.3. MARKET ANALYSIS AND FORECAST
    • 13.3.1. Total Positive Airway Pressure Device Market
      • 13.3.1.1. Continuous Positive Airway Pressure Device Market
      • 13.3.1.2. Auto-Titrating Positive Airway Pressure Device Market
      • 13.3.1.3. Bi-Level Positive Airway Pressure Device Market
    • 13.3.2. Total Sleep Therapy Interface Market
      • 13.3.2.1. Nasal Mask Market
      • 13.3.2.2. Full-Face Mask Market
      • 13.3.2.3. Nasal Pillow/Alternative Interface Market
  • 13.4. DRIVERS AND LIMITERS
    • 13.4.1. Market Drivers
    • 13.4.2. Market Limiters
  • 13.5. COMPETITIVE MARKET SHARE ANALYSIS

SLEEP DIAGNOSTIC DEVICE MARKET

  • 14.1. INTRODUCTION
    • 14.1.1. Type I Sleep Test
    • 14.1.2. Type II Sleep Test
    • 14.1.3. Type III Sleep Test
    • 14.1.4. Type IV Sleep Test
  • 14.2. MARKET OVERVIEW
  • 14.3. MARKET ANALYSIS AND FORECAST
    • 14.3.1. Total Sleep Diagnostic Device Market
    • 14.3.2. Type I Device Market
    • 14.3.3. Type II Device Market
    • 14.3.4. Type III Device Market
    • 14.3.5. Type IV Device Market
  • 14.4. DRIVERS AND LIMITERS
    • 14.4.1. Market Drivers
    • 14.4.2. Market Limiters
  • 14.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

  • 16.1. INTRODUCTION
  • 16.2. PRESS RELEASES
    • 16.2.1. Chart Industries
      • 16.2.1.1. AirSep Launches New Membrane and PSA Nitrogen Systems for On-Site Gas Generation
      • 16.2.1.2. Chart Completes Acquisition of Hudson Products
      • 16.2.1.3. Chart Acquires VCT Vogel
      • 16.2.1.4. Chart Announces Executive Succession Plan
      • 16.2.1.5. Chart announces acquisition of Hetsco
    • 16.2.2. Dräger
      • 16.2.2.1. First quarter of 2018: Drager off to a weak start to the fiscal year
      • 16.2.2.2. Fiscal year 2017: Drager continues to grow and improve earnings
      • 16.2.2.3. Drager increases both net sales and earnings
      • 16.2.2.4. New NIV ventilation mask with silicone sealing lip
      • 16.2.2.5. Savina 300 Select: The turbo in the ICU
      • 16.2.2.6. Oxylog VE300: A sturdy life saver in emergency response
      • 16.2.2.7. Drager acquires majority stake in Hamburg-based start-up bentekk
      • 16.2.2.8. Fiscal year 2016: Drager sees significant increase in earnings despite decline in net sales
    • 16.2.3. Drive DeVilbiss Healthcare, Inc.
      • 16.2.3.1. Drive DeVilbiss Healthcare Becomes Exclusive Distributor of the Uccello Kettle
      • 16.2.3.2. Drive DeVilbiss Healthcare Adds New CEO to Its Leadership Team
      • 16.2.3.3. Drive DeVilbiss 10 Liter Oxygen Concentrator Wins 2017 HME Business New Product Award
      • 16.2.3.4. Drive DeVilbiss Healthcare Introduces the Smallest, Lightest 10 Liter Oxygen Concentrator on the Market
      • 16.2.3.5. Drive DeVilbiss Acquires Sidhil Group Limited, The U.K.'s Leading Manufacturer of Hospital and Home Healthcare Beds
      • 16.2.3.6. Clayton, Dubilier & Rice Makes Significant Investment in Drive DeVilbiss Healthcare in Partnership with Existing Management
    • 16.2.4. Fisher & Paykel
      • 16.2.4.1. New research shows significant benefits for COPD patients in the home using Fisher & Paykel Healthcare's myAirvo
      • 16.2.4.2. Ground Breaking Research Shows Efficacy of Optiflow™ Nasal High Flow Therapy
      • 16.2.4.3. Strong Half Year Result from Fisher & Paykel Healthcare: Record Net Profit of NZ$81.3 Million
      • 16.2.4.4. Fisher & Paykel Healthcare wins patent case against ResMed in UK court
      • 16.2.4.5. Pip Greenwood Appointed to Fisher & Paykel Healthcare Board
      • 16.2.4.6. Fisher & Paykel Healthcare Reports Record Annual Result, Net Profit Up 18%
      • 16.2.4.7. Fisher & Paykel Healthcare Launches New CPAP Device
      • 16.2.4.8. Fisher & Paykel Healthcare Releases New Infant Cannula
      • 16.2.4.9. Prestigious Red Dot Award for Fisher & Paykel Healthcare's New Brevida Mask
      • 16.2.4.10. Former Employee Pleads Guilty to Charges
      • 16.2.4.11. Fisher & Paykel Healthcare's Brevida Mask Takes Out Top Design Award
    • 16.2.5. GE Healthcare
      • 16.2.5.1. Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
      • 16.2.5.2. Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom's healthcare sector
      • 16.2.5.3. GE Healthcare and Navicent Health Enter Relationship to Reduce Costs, Improve Patient Care and Target $150 Million in Savings over Six Years
      • 16.2.5.4. Clover Biopharmaceuticals selects GE's FlexFactory biomanufacturing platform for its new production facility in China
      • 16.2.5.5. Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years
      • 16.2.5.6. GE Healthcare acquires bioprocessing start-up Puridify
      • 16.2.5.7. GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology
      • 16.2.5.8. Catherine Estrampes appointed President & CEO of GE Healthcare Europe
      • 16.2.5.9. Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences
      • 16.2.5.10. GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes
      • 16.2.5.11. Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
      • 16.2.5.12. Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey
      • 16.2.5.13. United BioPharma selects GE Healthcare's FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals
      • 16.2.5.14. GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies
      • 16.2.5.15. GE Healthcare invests in Zenith Technologies, the companies to deliver together next-generation of biopharma automation
      • 16.2.5.16. Arven Pharmaceuticals selects GE Healthcare's FlexFactory to improve Turkish and regional access to biopharmaceuticals
    • 16.2.6. Invacare
      • 16.2.6.1. Invacare Appoints Kathleen Leneghan Chief Financial Officer
      • 16.2.6.2. Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2017
      • 16.2.6.3. Invacare Announces North America Reduction in Force as Part of Continued Cost Realignment
      • 16.2.6.4. Invacare Announces Departure of Chief Financial Officer
      • 16.2.6.5. Invacare Expands Healthcare Informatics Platform to Oxygen Technology
      • 16.2.6.6. Invacare Corporation Appoints Barbara Bodem to Board of Directors
      • 16.2.6.7. Invacare Corporation Announces Closure of China Manufacturing Facility in Line with Strategic Transformation
      • 16.2.6.8. Invacare Continues Realignment as Part of Its Ongoing Transformation
      • 16.2.6.9. Invacare Introduces 'Outcomes by Design' Program for Post-Acute Care Facilities
      • 16.2.6.10. Invacare Reports Completion of Consent Decree Milestones
    • 16.2.7. Medtronic
      • 16.2.7.1. Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
      • 16.2.7.2. Medtronic and Lehigh Valley Health Network Sign Strategic Partnership Agreement Focused on Delivering Value-Based Healthcare Programs
      • 16.2.7.3. Medtronic Reports Third Quarter Financial Results
      • 16.2.7.4. Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
      • 16.2.7.5. Medtronic and Philips Partner to Innovate in Lung Cancer Management
      • 16.2.7.6. Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
      • 16.2.7.7. Medtronic Releases Fiscal Year 2017 Integrated Performance Report
      • 16.2.7.8. Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities
      • 16.2.7.9. Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
      • 16.2.7.10. Medtronic to Establish Innovation Center in Chengdu
      • 16.2.7.11. Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health
      • 16.2.7.12. Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
      • 16.2.7.13. Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport™ HT70 and Newport™ HT70 Plus Ventilators
      • 16.2.7.14. New Partnership Between Medtronic and Atlas General Hospital Brings Advanced Surgical Technologies and Treatment Options to Serbia
      • 16.2.7.15. Medtronic Announces New, Outcome-Based Learning Program
      • 16.2.7.16. Invacare Reports Completion of Consent Decree Milestones
    • 16.2.8. Natus
      • 16.2.8.1. NATUS MEDICAL ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
      • 16.2.8.2. NATUS CONFIRMS RECEIPT OF NOTICE OF VOCE CAPITAL'S INTENT TO NOMINATE DIRECTOR CANDIDATES TO REPLACE 50% OF THE NATUS BOARD
      • 16.2.8.3. NATUS ANNOUNCES $30 MILLION SHARE REPURCHASE PROGRAM
      • 16.2.8.4. NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
      • 16.2.8.5. NATUS APPOINTS LESLIE MCDONNELL AS VICE PRESIDENT AND GENERAL MANAGER OF ITS NEWBORN CARE BUSINESS UNIT
      • 16.2.8.6. NATUS TO BE EXCLUSIVE U.S. AGENT FOR THE FIRST NEONATAL MRI DEVICE
      • 16.2.8.7. NATUS COMPLETES ACQUISITION OF NEUROSURGERY ASSETS FROM INTEGRA LIFESCIENCES
      • 16.2.8.8. NATUS MEDICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS
      • 16.2.8.9. NATUS COMPLETES ACQUISITION OF GN OTOMETRICS BUSINESS
    • 16.2.9. Omron
      • 16.2.9.1. OMRON's Fiscal 2017 Net Income Jumps 37.3%, to Record JPY63.2 Billion
      • 16.2.9.2. "Near-future designs": OMRON's challenge for the future - OMRON establishes OMRON SINIC X Corporation
      • 16.2.9.3. Notice Regarding the status (Progress Report) of Acquisition of Treasury Stock
      • 16.2.9.4. OMRON Announces the Establishment of OMRON EXPERTLINK Co., Ltd.
      • 16.2.9.5. Directors, Auditors and Executive Officers Changes
      • 16.2.9.6. Announcing the Founding of the Edgecross Consortium
      • 16.2.9.7. OMRON Completes Acquisition of Microscan Systems
      • 16.2.9.8. OMRON Completes Acquisition of Sentech
      • 16.2.9.9. Personnel changes
      • 16.2.9.10. Executive Officer Changes of Affiliated Company
      • 16.2.9.11. OMRON, RIKEN Agree to Set up RBOmC, Cooperate in Comprehensive Collaboration
      • 16.2.9.12. Personnel changes
      • 16.2.9.13. Notice regarding Capital and Business Partnerships with AliveCor
      • 16.2.9.14. Executive Officer Changes of Affiliated Company
      • 16.2.9.15. OMRON Announces Change of Representative Directors
      • 16.2.9.16. Directors, Auditors and Executive Officers Changes
      • 16.2.9.17. OMRON opens regional head office in South Korea
    • 16.2.10. Philips
      • 16.2.10.1. Philips and Samsung team up to expand the connected health ecosystem
      • 16.2.10.2. Saratoga Hospital partners with Philips to improve patient care and safety
      • 16.2.10.3. Northwell Health improves patient care and satisfaction with Philips integrated patient monitoring solutions
      • 16.2.10.4. Philips launches AI platform for healthcare
      • 16.2.10.5. Philips launches FocusPoint, an intuitive web-based application to help reduce costs and improve operational efficiencies
      • 16.2.10.6. Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market
      • 16.2.10.7. Vitor Rocha succeeds Brent Shafer as CEO of Philips North America
      • 16.2.10.8. Philips teams with 3D printing industry leaders 3D Systems and Stratasys
      • 16.2.10.9. Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
      • 16.2.10.10. Philips launches cloud-connected Trilogy in North America
      • 16.2.10.11. Philips adds Pillows cushion option to award-winning DreamWear mask line
      • 16.2.10.12. Philips-sponsored study suggests positive airway pressure therapy could reduce COPD patient hospitalization
      • 16.2.10.13. Philips simplifies travel for sleep apnea patients with new compact and connected DreamStation Go sleep therapy device
      • 16.2.10.14. Philips and Phoenix Children's Hospital sign 15-year agreement to redefine imaging, patient monitoring and clinical informatics in pediatric care
      • 16.2.10.15. Philips IntelliSpace Perinatal named 2017 KLAS Category Leader for Labor and Delivery Software
      • 16.2.10.16. Philips launches IntelliSpace Enterprise Edition, an industry-first managed service for hospital-wide healthcare informatics
      • 16.2.10.17. Philips receives FDA 510(k) clearance to market the next-generation of IntelliVue Guardian Solution to aid clinicians in identifying potential signs of early patient deterioration
    • 16.2.11. ResMed
      • 16.2.11.1. ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018
      • 16.2.11.2. ATS Foundation and ResMed Announce Two-Year Research Grant in Sleep-Disordered Breathing
      • 16.2.11.3. SleepScore Labs Acquires Sleep.ai
      • 16.2.11.4. ResMed Hires Bobby Ghoshal as First Chief Technology Officer
      • 16.2.11.5. ResMed Joins MedTech Europe
      • 16.2.11.6. VGM & Associates Extends Its Membership Agreement with Brightree
      • 16.2.11.7. SleepScore Labs Launches First Sleep Ecosystem Leveraging Accurate Big Data
      • 16.2.11.8. ResMed Announces Its Premier Portable Oxygen Concentrator, Mobi
      • 16.2.11.9. SleepScore Announces Exclusive Retail Partnership with Williams-Sonoma, Inc.
      • 16.2.11.10. ResMed Elects Karen Drexler to Its Board of Directors
      • 16.2.11.11. Statement by ResMed on United Kingdom Case with Fisher & Paykel
      • 16.2.11.12. SleepScore Labs Launches the World's Most Advanced Sleep Improvement System
      • 16.2.11.13. ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP
      • 16.2.11.14. ResMed AirFit N20 Classic CPAP Mask Launches in Europe
      • 16.2.11.15. Brightree Appoints Robert Dean to Lead Home Health & Hospice Division
      • 16.2.11.16. ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel
      • 16.2.11.17. ResMed's European Patents Infringed by Fisher & Paykel in Germany
      • 16.2.11.18. Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMed's AirView
      • 16.2.11.19. ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2017
      • 16.2.11.20. Brightree Acquires AllCall Connect for Expanded CPAP Resupply Capabilities and Better Patient Care
      • 16.2.11.21. ResMed Awarded Best Design for "Game-changing" CPAP, CPAP Masks
      • 16.2.11.22. Brightree Acquires Conduit Technology, LLC
      • 16.2.11.23. World's Smallest CPAP, ResMed's AirMini, Now Shipping to HMEs
      • 16.2.11.24. Introducing the Softest CPAP Mask from ResMed
      • 16.2.11.25. ResMed Unveils AirMini - the World's Smallest CPAP
      • 16.2.11.26. ATS Foundation Announces $100,000, Two-year Non-Invasive Ventilation Research Grant
      • 16.2.11.27. Brightree Expands Sleep Therapy Capabilities with ResMed's AirView Platform
      • 16.2.11.28. ResMed and BMC/3B Medical Settle Global Litigation
      • 16.2.11.29. ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
      • 16.2.11.30. FDA Clears World's Smallest CPAP, ResMed AirMini™
      • 16.2.11.31. Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep
    • 16.2.12. Teleflex
      • 16.2.12.1. Teleflex Reports First Quarter 2018 Results
      • 16.2.12.2. Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
      • 16.2.12.3. Teleflex Completes Previously Announced CEO Transition
      • 16.2.12.4. Teleflex Signs New Agreement with HealthTrust for Respiratory Heaters & Accessories
      • 16.2.12.5. Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
      • 16.2.12.6. Teleflex Receives Innovative Technology Designation from Vizient for LMA® Gastro™ Airway
      • 16.2.12.7. Teleflex Incorporated Completes Acquisition of NeoTract
      • 16.2.12.8. Teleflex Completes Acquisition of Pyng Medical Corp.
      • 16.2.12.9. Teleflex Incorporated Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer
      • 16.2.12.10. Teleflex Incorporated Completes Acquisition of Vascular Solutions
      • 16.2.12.11. Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
    • 16.2.13. Vyaire Medical
      • 16.2.13.1. Vyaire Medical executes on its plan to become a global leader in respiratory care
      • 16.2.13.2. Vyaire Medical Acquires Revolutionary Medical Devices, Inc.
      • 16.2.13.3. Vyaire Medical Acquires Ciel Medical
Back to Top